-
公开(公告)号:EP3294735A1
公开(公告)日:2018-03-21
申请号:EP16725672
申请日:2016-05-11
申请人: VERTEX PHARMA
发明人: FARMER LUC J , BOYD MICHAEL JOHN , SHANNON DEAN , WALDO MICHAEL , NTI ADDAE KWARNE W , ZHANG YUEGANG
IPC分类号: C07D471/04 , A61K31/506 , A61P31/16
CPC分类号: C07D471/04 , A61K31/4965 , A61K31/506 , A61K45/06 , C07B2200/13
摘要: include Hydrate 2 of Compound (1), Hydrate 3 of Compound (1), Form A of Compound (1), Form B of Compound (1), Form C of Compound (1), Form D of Compound (1), and amorphous Compound (1). Such polymorphic forms are useful for treating influenza, inhibiting the replication of influenza viruses, or reducing the amount of influenza viruses in a biological sample or in a subject.
-
公开(公告)号:EP3294717A1
公开(公告)日:2018-03-21
申请号:EP16725308
申请日:2016-05-11
申请人: VERTEX PHARMA
IPC分类号: C07D239/42 , C07D471/04
CPC分类号: C07D471/04 , C07D239/42
摘要: in the presence of water, an organic solvent, a base, and a transition metal catalyst to generate a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
-